All News

|
News Release
The U.S. Food and Drug Administration approved two new gene therapies to treat sickle cell disease — one a gene-editing and the other a gene-addition approach. Nearly 100,000 people in the United States — and millions worldwide — have been diagnosed with this painful, life-threatening genetic blood disease. To help explain the historic importance...
Showing 10 out of 1684 results

|
NHLBI in the Press
Omega-3 fatty acids, which are abundant in fish and fish oil supplements, appear promising for maintaining lung health.

|
NHLBI in the Press
Adults with COPD who used a daily bronchodilator with LAMA-LABA therapy compared to ICS-LABA were less likely to seek medical care for flare-ups or be hospitalized for pneumonia.

|
NHLBI in the Press
Children and parents who received coaching about heart-healthy living experienced better long-term outcomes compared to families who received standard treatment.

|
NHLBI in the Press
For every hour an adolescent went to bed earlier than normal each night, they got an extra 41-42 minutes of sleep

|
NHLBI in the Press
Among adults who received a pulmonary function test, a greater proportion of Black adults were reclassified as having reduced lung function if a race-neutral equation was used compared to a race-specific equation.

|
NHLBI in the Press
Adults with or at risk for cardiovascular disease reported being less likely to use wearable health trackers, including those designed to monitor changes in heart rate or rhythm.

|
NHLBI in the Press
After following more than 4,000 adults with COPD for almost 10 years, researchers found those with extra mucus accumulating in their airways had an associated increased risk for dying early. These findings may advance research to identify targeted approaches for treatment.

|
NHLBI in the Press
Researchers found adding coronary artery calcium scores to 10-year heart disease risk calculators improved predictions for middle-aged to older adults, but polygenic risk scores, which provide general genetic insight, didn’t have the same effect.

|
NHLBI in the Press
Study underscores the importance of cardiovascular disease risk-monitoring and prevention for people who have had at least one pregnancy affected by complications.

|
NHLBI in the Press
Vigorous exercise does not appear to increase the risk of death or life-threatening arrhythmia for people with hypertrophic cardiomyopathy.